NCT03175666 2025-02-21
QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy
ImmunityBio, Inc.
Phase 1/2 Withdrawn
ImmunityBio, Inc.
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Weill Medical College of Cornell University
University of Texas Southwestern Medical Center
University of Maryland, Baltimore